Two Old Farts Making Noises

Unlocking the Future of AI in Healthcare with CEO of Optain | Lost Dollar Business Club Ep 513

June 22, 2024 Michael, David, John , Steven, and special Jeff Dunkel Season 3 Episode 513
Unlocking the Future of AI in Healthcare with CEO of Optain | Lost Dollar Business Club Ep 513
Two Old Farts Making Noises
More Info
Two Old Farts Making Noises
Unlocking the Future of AI in Healthcare with CEO of Optain | Lost Dollar Business Club Ep 513
Jun 22, 2024 Season 3 Episode 513
Michael, David, John , Steven, and special Jeff Dunkel

Send us a Text Message.

Join us this week on Business Club as we delve into the revolutionary world of AI in healthcare with special guest, Jeff Dunkel, CEO of Optain. Optain’s groundbreaking non-invasive clinical support tools harness AI-enabled algorithms to analyze full-color retinal images, screening for referable diseases and evaluating patient health with unprecedented accuracy.

In this engaging episode, we explore Jeff Dunkel’s impressive journey as a self-proclaimed “science innovation nerd.” With a rich background in leading committees that shape health sector innovation—including HHS Innovation, FDA Medical Device Epidemiology, and the Center for Global Health Innovation—Jeff has authored pivotal comments on bills passed by Congress and the Senate, earning White House recognition and achieving FDA clearance status.

We dive deep into the government's perspective on innovation and the distinct advantages for companies that generate new, objective data points with AI. Jeff shares his insights on what it takes to succeed in innovation, drawing from his experience advising over 30 companies. Discover the four key factors that differentiate successful companies: meeting clinical needs, addressing fit form function, achieving fiscal benefits, and maintaining true differentiation.

As the CEO of Optain, Jeff is a pioneer in oculomics—an innovative field that uses biomarkers to identify diseases through non-invasive eye images. Learn how Optain is expanding globally, tackling market pressure points, and gaining commercial traction in a challenging fundraising landscape.

Don’t miss our “Lost and Found” segment, where we discuss the latest geopolitical developments involving North Korea and Russia, the surprising trends in crispy pints, and major corporate news, including Allstate’s $1.4 billion loss and Dell’s new remote work policies.

Tune in for an enlightening discussion that promises to inspire and inform on the cutting edge of AI and healthcare innovation.

#aihealthcare  #innovation  #businessclub  #Optain #JeffDunkel #healthtech   #Oculomics #fda  #medicalinnovation  #startupsuccess  #lostandfound #healthtechnologyinnovator #twooldfartsmakingnoises #youtubeshorts #youtubeindia #youtubetalkshow #2ofentertainment #lostdollarbusinessclub   

Our Media
https://linktr.ee/tofentertainment

Our Merch
https://2oldfarts.vip/

Show Notes

Send us a Text Message.

Join us this week on Business Club as we delve into the revolutionary world of AI in healthcare with special guest, Jeff Dunkel, CEO of Optain. Optain’s groundbreaking non-invasive clinical support tools harness AI-enabled algorithms to analyze full-color retinal images, screening for referable diseases and evaluating patient health with unprecedented accuracy.

In this engaging episode, we explore Jeff Dunkel’s impressive journey as a self-proclaimed “science innovation nerd.” With a rich background in leading committees that shape health sector innovation—including HHS Innovation, FDA Medical Device Epidemiology, and the Center for Global Health Innovation—Jeff has authored pivotal comments on bills passed by Congress and the Senate, earning White House recognition and achieving FDA clearance status.

We dive deep into the government's perspective on innovation and the distinct advantages for companies that generate new, objective data points with AI. Jeff shares his insights on what it takes to succeed in innovation, drawing from his experience advising over 30 companies. Discover the four key factors that differentiate successful companies: meeting clinical needs, addressing fit form function, achieving fiscal benefits, and maintaining true differentiation.

As the CEO of Optain, Jeff is a pioneer in oculomics—an innovative field that uses biomarkers to identify diseases through non-invasive eye images. Learn how Optain is expanding globally, tackling market pressure points, and gaining commercial traction in a challenging fundraising landscape.

Don’t miss our “Lost and Found” segment, where we discuss the latest geopolitical developments involving North Korea and Russia, the surprising trends in crispy pints, and major corporate news, including Allstate’s $1.4 billion loss and Dell’s new remote work policies.

Tune in for an enlightening discussion that promises to inspire and inform on the cutting edge of AI and healthcare innovation.

#aihealthcare  #innovation  #businessclub  #Optain #JeffDunkel #healthtech   #Oculomics #fda  #medicalinnovation  #startupsuccess  #lostandfound #healthtechnologyinnovator #twooldfartsmakingnoises #youtubeshorts #youtubeindia #youtubetalkshow #2ofentertainment #lostdollarbusinessclub   

Our Media
https://linktr.ee/tofentertainment

Our Merch
https://2oldfarts.vip/